Call Us Today



Intellepedia – IP News Center

Patent: U.S. Supreme Court reaffirms Patent Exhaustion

the image depicts the logo of the electronic comapny LG as the post is about a patent exhaustion suit between LG and Quanta

In its recent verdict in the most talked about case of LG Electronics v. Quanta (decided on June 9, 2008), the United States Supreme Court reaffirmed the doctrine of patent exhaustion. The case witnessed LG suing Quanta for using certain Intel chips incorporating patents owned by LGE. The point of contention was that inspite of the presence of a set of agreements (a license agreement and a master agreement) effectuated to provide notice to the third parties that license is only for using the Intel chips with other Intel or LG products, Quanta used the chips with other products in...

Continue reading

Intellectual Property: Indian Diet Whisky and Vodka gets US patent

The image depicts a photograph of the fruit Garcinia Cambogia as the post is about US patents over diet whiskey and vodka and it is one of the main ingredient of the same.

Vijay Malaya’s Vittal Mallya Scientific Research Foundation in Bangalore has developed the technology of manufacturing diet whisky and diet vodka which helps to fight obesity, it actually breaks down the sugar cells and fat cells. Moreover, this technology has been granted US patents.These legitimate drinks have been tested in laboratories and have proved that they burn calories. The main ingredient in these drinks is a fruit from the Garcinia family, it’s the malbar tamrind. The biological name of the fruit is Garcinia Cambogia. The fruit mainly contains a primary acid known as hydro citric acid which brings weight loss.The research...

Continue reading

IP Licensing: Educational Community License Version 1.0 – By Dr.Kalyan C. Kankanala, CKO, Brain League IP Services Pvt. Ltd Now BananaIP

The image depicts the logo of the open source initiative as the post is about Educational Community License

The Educational Community License is one of the special purpose licenses approved by the Open Source Initiative. The license is used by certain educational institutions while distributing software. Rights The license provides certain rights to a person receiving a software, documentation or other materials under the agreement. The license comes into effect as soon as a person obtains, uses or copies the work provided under the license. The following rights are provided over the work under the license: Right to use; Right to copy; Right to modify; Right to merge; Right to publish; Right to distribute; and Right to sublicense. Conditions A person exercising rights...

Continue reading

Patent: Red Hat settles patent suit

The image depicts the logo of the software company Red Hat as the post is about a patent dispute between Red Hat and Firestar.

Firestar sued Red Hat for violation of its US patent, which relates to a method for interfacing an object-oriented software application with a relational database to facilitate access to the relational database. Firestar alleged that the Hibernate package distributed by Red Hat violates its patent. Red Hat has now settled the patent suit with Firestar and Data-Tern, the assignee of the patent. Under the settlement all products of Red Hat will not be liable for violation of Firestar and Data-Tern's patents. Other details of the settlement have not been disclosed. Submitted by: Kalyan C. Kankanala   Source/Attribution here. (Governed by Creative Commons License...

Continue reading

Patent: Apotex USA, Inc. v. Merck & Co., 254 F.3d 1031 (Fed. Cir. 2001) – case note

The image depicts the logo of the pharma company Merck & co as the post is about a patent dispute between Merck & co and Apotex USA, inc.

Author: Ken Aoki, Patent Agent, Japan CASE FACTS • Apotex’s patents cover a process for making an enalapril formulation (high blood pressure drug). • Merck has been selling ealapril (VASOTEC) since 1983. • Merck owns a product patent but does not own a manufacturing process patent. • Later, Merck disclosed ingredients of the enalapril formulation: o in a French pharmaceutical dictionary (1988); o in a Canadian product monograph (1992); and o in a Canadian trial (1994). • After the Canadian trial, Dr. Sherman, an Apotex official, allegedly conceived the process. ISSUE 1. Can Merck rely on activities outside the US to deny suppression or concealment in 102(g)? 2. Should Apotex’s patents be invalidated based on...

Continue reading

Patent: HP and Acer settle patent dispute

The image depicts the logo of the company HP as the post is about a patent dispute between HP and Acer.

A patent dispute began in March 2007, when the reigning No. 1 PC maker HP filed a suit against Taiwanese based computer maker Acer, for infringing on five patents owned by HP, in the U.S. District Court of Wisconsin. In April 2007, HP also filed a complaint to the U.S. International Trade Commission for infringement of four more patents by Acer. The patents in dispute covered technologies such as power management in notebooks, read/write optical drives, digital bus arrangement, thermal management and video control. The purpose of the suits was to stop Acer from importing and selling its PCs in...

Continue reading

Patent: Microsoft loses patent suit against Alcatel-Lucent

The image depicts the logo of the company Alcatel-Lucent as the post is about the patent suit it won against microsoft.

The US District Court of San Diego held that Microsoft is liable for infringing two patents owned by Alcatel-Lucent. The patents held by Alcatel-Lucent relate to handwriting recognition technology and menu structure for selecting calendar dates. The jury ordered Microsoft to pay damages to the tune of 367 million dollars to Alcatel-Lucent. Microsoft plans to appeal against the decision of the court. Submitted by: Kalyan C. Kankanala Source/Attribution here. (This image is in public domain)...

Continue reading

Trademarks: Adidas wins 305 million dollars as damages

The image is the logo of the brand Adidas as the post is about a trademark case that Adidas won.

Collective Brands Inc. sold sports shoes having two and four stripes on their sides; Adidas sued Collective for trademark infringement of its mark having three stripes. After comparing the shoes sold by Collective with those of Adidas, the district court in Portland held Collective liable for actual and punitive damages and profits of 305 million dollars. This is considered to be one of the highest damages awards in US Trademark jurisprudence. Submitted by: Kalyan C. Kankanala Source/Attribution here. (This image is in public domain)...

Continue reading

StartUps and IP: The importance of Intellectual Property for Entrepreneurs – A short talk with Dr. Sudhir Borgonha

The image depicts the word startup in the background with a silhouette of a man jumping, as the post is about startups and Intellectual Property for Entrepreneurs.

Dr. Sudhir is a graduate from St. John’s Medical College and Sloan School of Management, MIT. He has been on the founding team of three life sciences companies which include Angstrom Medica, Massachusetts, a nanotechnology based orthopedics application Company; Triesta Sciences, California, a genomics based cancer research organization and ClinTest International, Michigan. He currently serves as a CEO of ClinTest International and also runs Sandbox, a life Sciences Incubator. Q1. What is the value of IP for entrepreneurs in knowledge driven sectors? IP for entrepreneurs is of tremendous value. Knowledge driven sectors are essentially that - knowledge driven. To capture that...

Continue reading

Patent: AstraZeneca and Ranbaxy settle patent case

The featured image is the logo of Ranbaxy Laboratories as the post is about a patent case between AstraZeneca and Ranbaxy.

AstraZeneca holds patents over Nexium, an anti-ulcer drug. The Company filed a patent infringement suit against Ranbaxy in 2005 alleging that Ranbaxy is infringing its patents relating to Nexium. Ranbaxy applied to USFDA for marketing approval of a low cost version of Nexium and has recently been granted the approval.Under the settlement agreement, Ranbaxy agreed to launch the generic version of Nexium in 2014 after the expiry of AstraZeneca's first patent on the molecule. As a part of the settlement deal, AstraZeneca agreed to outsource to Ranbaxy, a part of the supply and manufacture of Nexium. Ranbaxy agreed under the...

Continue reading

Subscribe For Intellepedia IP News Updates

Signup for our Intellepedia newsletter and get notified when we publish new articles on IP!